🌅 Today's Morning Call
|
S&P Futures
7,128.25
▲ +9.00 (+0.13%)
|
Nasdaq Futures
26,707.25
▲ +28.75 (+0.11%)
|
Dow Futures
49,389.00
▲ +116.00 (+0.24%)
|
|
10Y Treasury
4.25%
▼ -0.06%
|
US Dollar
98.22
▼ -0.07 (-0.07%)
|
Bitcoin
$75,323
▲ +$1,508 (+2.04%)
|
Data as of 8:09 AM ET
Good morning! Futures are inching higher this Monday morning, with the Dow leading the charge up 116 points as investors digest a mixed bag of corporate news and policy moves. The most interesting action is happening in a corner of biotech you probably weren't watching until now: psychedelic drug developers are soaring after President Trump signed an executive order pushing the FDA to speed up drug reviews. Here's what's moving markets before the bell.
👀 What to Watch Today
The psychedelic therapy space is getting serious attention today after Trump's executive order targeting FDA review timelines. ATAI Life Sciences, Compass Pathways (CMPS), and Field Trip Health (FTRP) are all jumping in pre-market as investors bet on faster approval pathways for treatments targeting depression, PTSD, and other mental health conditions. This executive action could reshape the timeline for an entire emerging drug class.On the corporate restructuring front, Honeywell (HON) is offloading its productivity solutions and services unit to Brady Corp for $1.4 billion. The deal marks another step in Honeywell's ongoing portfolio optimization, allowing the industrial giant to focus capital on higher-growth aerospace and automation segments. Expect analyst commentary throughout the day on whether this valuation reflects fair value or leaves money on the table.
Meanwhile, Tesla (TSLA) is facing fresh headwinds as owner protests gain momentum over self-driving hardware concerns. Reports suggest international criticism is mounting over what protesters claim is outdated hardware that can't deliver on Full Self-Driving promises. This adds another layer of scrutiny to a company already navigating production challenges and competitive pressure in the EV space.
🌏 Overnight Recap
Asian markets posted modest gains overnight, with technology shares leading after a stabilization in Treasury yields provided some relief. Japan's Nikkei added 0.4% while Hong Kong's Hang Seng climbed 0.6%, shrugging off lingering trade concerns. Chinese tech stocks found buyers as sentiment improved following better-than-expected retail sales data released over the weekend.European markets opened mixed but trended higher into mid-session, with energy stocks catching a bid after Eni (E) announced a major offshore gas discovery in Indonesia's Ganal block. The find could significantly boost Eni's Asian production profile and comes at a time when European energy security remains a policy priority. The DAX is up 0.3% while the FTSE 100 trades flat.
Crypto markets continued their recent rally, with Bitcoin pushing above $75,000 for a 2% gain. The move higher comes amid renewed institutional interest and speculation that clearer regulatory frameworks may be emerging. Ethereum and other major altcoins are following Bitcoin's lead, with the broader crypto market cap expanding for the fifth consecutive session.
Sponsored Content
Trump’s Crypto Law Just Created a Massive Opportunity
Trump’s GENIUS Act has given crypto its first official federal framework. While attention stays on Bitcoin, one overlooked coin could benefit the most—backed by skyrocketing volume, early fund activity, and pro-crypto policy momentum.
📊 Pre-Market Movers
The standout sector in pre-market is clearly psychedelic therapeutics, with Compass Pathways (CMPS) up over 12% and ATAI Life Sciences (ATAI) gaining 9% as traders price in a potentially faster regulatory pathway. These aren't household names, but today's executive order puts them squarely in the spotlight as the FDA faces pressure to expedite reviews for novel mental health treatments. The sector has been starved for catalysts, and this policy shift delivers one.Honeywell (HON) is trading slightly higher, up about 0.8% as investors digest the $1.4 billion sale of its productivity unit to Brady Corp. The market seems to be interpreting this as a net positive, with proceeds likely earmarked for share buybacks or investments in higher-margin businesses like building automation and quantum computing initiatives.
On the flip side, Tesla (TSLA) is under pressure in pre-market trading, down roughly 1.2% as international protests over Full Self-Driving hardware limitations gain media attention. The timing is particularly sensitive given the company's premium valuation partly hinges on autonomous driving optionality. Mercedes-Benz (MBGYY) is getting a small bump, up 0.6%, after Samsung SDI announced its first EV battery supply agreement with the German automaker, diversifying Mercedes away from current suppliers.
🔍 Today's Watchlist
- Psychedelic biotech momentum: ATAI, CMPS, FTRP reaction to FDA acceleration order
- Honeywell's $1.4B divestiture impact on industrial sector M&A activity
- Tesla owner protests and potential regulatory scrutiny on self-driving claims
- Treasury yields pulling back: 10-year at 4.25% supporting growth stocks
- Energy sector strength following Eni's Indonesian gas discovery
Sponsored Content
Your 401k gained 18% last year. Gold gained 65%. When did that happen before?
In 2025 the S&P 500 returned 18%. Gold returned 65%. That gap hasn't shown up like that since the 1970s. And there's a specific reason analysts are focused on what happened next back then. The free...
🎯 The Morning Playbook
Today's setup favors selective risk-taking rather than broad beta exposure. With futures only modestly higher and Treasury yields easing, the environment supports growth and speculative plays but doesn't scream conviction. The psychedelic stocks offer high-risk, high-reward trades for those willing to play policy-driven momentum, but size positions accordingly given the volatility and relatively thin trading volumes in these names.For more conservative portfolios, the industrial sector deserves attention as Honeywell's divestiture could signal more M&A activity among conglomerates looking to streamline. Energy also looks constructive after Eni's discovery and with crude prices stabilizing near recent ranges. Watch how mega-cap tech responds to the yield decline, particularly names that sold off last week on rate concerns.
The key tension today is between modest optimism in futures and some genuine controversy brewing around high-profile names like Tesla and Elon Musk's X platform, which faces scrutiny in France. Stay nimble, respect the pre-market moves but verify them with volume once the bell rings, and remember that April trading can be choppy as earnings season approaches. Make it a smart one out there.